PL380849A1 - Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie - Google Patents

Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie

Info

Publication number
PL380849A1
PL380849A1 PL380849A PL38084906A PL380849A1 PL 380849 A1 PL380849 A1 PL 380849A1 PL 380849 A PL380849 A PL 380849A PL 38084906 A PL38084906 A PL 38084906A PL 380849 A1 PL380849 A1 PL 380849A1
Authority
PL
Poland
Prior art keywords
dihydrothiene
pyridil
chlorophenyl
acetate
manufacture
Prior art date
Application number
PL380849A
Other languages
English (en)
Inventor
Zbigniew Majka
Andrzej Wojciech Sawicki
Andrzej Trzepałka
Original Assignee
Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Spółka Z Ograniczoną Odpowiedzialnością filed Critical Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL380849A priority Critical patent/PL380849A1/pl
Priority to PCT/EP2007/060905 priority patent/WO2008046792A1/de
Publication of PL380849A1 publication Critical patent/PL380849A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL380849A 2006-10-17 2006-10-17 Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie PL380849A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL380849A PL380849A1 (pl) 2006-10-17 2006-10-17 Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie
PCT/EP2007/060905 WO2008046792A1 (de) 2006-10-17 2007-10-12 KRISTALLINE FORM DES RAZEMISCHEN METHYL-α-(2-CHLORPHENYL)-2-(6,7-DIHYDROTHIENO[3,2-C]PYRIDIN-5(4H))-ACETATS,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL380849A PL380849A1 (pl) 2006-10-17 2006-10-17 Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie

Publications (1)

Publication Number Publication Date
PL380849A1 true PL380849A1 (pl) 2008-04-28

Family

ID=39158230

Family Applications (1)

Application Number Title Priority Date Filing Date
PL380849A PL380849A1 (pl) 2006-10-17 2006-10-17 Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie

Country Status (2)

Country Link
PL (1) PL380849A1 (pl)
WO (1) WO2008046792A1 (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1353928B1 (en) * 2001-01-24 2006-12-27 Cadila Healthcare Ltd. Process for preparing clopidogrel
CA2352520C (en) * 2001-07-06 2007-10-02 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
IL166593A0 (en) * 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
EP1723141A4 (en) * 2004-03-05 2007-10-10 Ipca Lab Ltd MOST TECHNICAL PROCESS FOR THE PREPARATION OF CLOPIDOGRAPHYDROGENSULFATE
CZ295920B6 (cs) * 2004-10-18 2005-11-16 Zentiva, A. S Způsob výroby klopidogrelu
CZ299213B6 (cs) * 2005-03-08 2008-05-21 Zentiva, A. S Zpusob racemizace R(-) izomeru methylesteru kyseliny (2-chlorfenyl)-6,7-dihydro-thieno[3,2-c]pyridin-5(4H)-octové

Also Published As

Publication number Publication date
WO2008046792A1 (de) 2008-04-24

Similar Documents

Publication Publication Date Title
IL187689A0 (en) Thienopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors
IL189667A0 (en) 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
PL2189573T3 (pl) Struktura sztucznej murawy i sposób jej wytwarzania
PL2122058T3 (pl) Sztuczna murawa i sposób wytwarzania murawy tego rodzaju
AU2003251247A1 (en) Methods for preparation of olanzapine polymorphic form i
WO2007125544A3 (en) Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
GB0327822D0 (en) Method for manufacturing a prosthesis made prior to implant placement
PT1618111E (pt) Sais de clopidogrel e processo de preparação
GB0906857D0 (en) Crystalline form of benzothiophene compound and process for preparation thereof
EP2185622A4 (en) PROCESS FOR PREPARING COPOLYMERS OF LACTID AND A 1: 4-3: 6-DIANHYDROHEXITOL
IL192825A0 (en) A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-ßé?- (2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-C]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
EP1764416A4 (en) METHOD OF PRODUCTION OF THEANINE
ZA200608569B (en) Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide
PL1828252T3 (pl) Ulepszona metoda wytwarzania pochodnych hydroksy-alkilo-celulozy o wysokiej odporności na działanie enzymów
HU0700809D0 (en) Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate
PL377084A1 (pl) Nowe związki olanzapiny i sposób ich wytwarzania
PL364192A1 (pl) Sposób wytwarzania syntetycznych izoparafin
WO2005003138A3 (en) Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
WO2008108742A3 (en) Polymorphic forms of clopidogrel hydrobromide
PL376058A1 (pl) Nowe pochodne 8-chloro-5,5-dioksoimidazo[1,2-b][1,4,2]benzoditiazyny i sposób ich otrzymywania
PL371171A1 (pl) Nowe pochodne takryny i sposób ich otrzymywania
HK1116479A (en) Thienopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors
PL371700A1 (pl) Nowe pochodne okta-μ₃-oxododeka-μ-karboksylanocyklohexacyrkonu(IV) oraz sposób ich wytwarzania
PL355037A1 (pl) Nowy sposób wytwarzania olanzapiny
PL363585A1 (pl) Sposób wytwarzania rzutków strzeleckich

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)